Management and treatment of special populations with hepatitis C virus infection in the era of direct-acting antiviral agents
Chronic Hepatitis C is a global epidemic, and people with different sexes, ages, races, and nationalities are susceptible to hepatitis C virus (HCV) infection. This article elaborates on the management method and individualized treatment regimens for special populations, including children with hepa...
Main Author: | LI Junli |
---|---|
Format: | Article |
Language: | zho |
Published: |
Editorial Department of Journal of Clinical Hepatology
2018-02-01
|
Series: | Linchuang Gandanbing Zazhi |
Online Access: | http://www.lcgdbzz.org/qk_content.asp?id=8746 |
Similar Items
-
Hepatitis C virus pharmacogenomics in Latin American populations: implications in the era of direct-acting antivirals
by: Trinks J, et al.
Published: (2017-03-01) -
Treatment of hepatitis C virus genotype 3 infection with direct-acting antiviral agents
by: L.P. Zanaga, et al. -
Current research on hepatitis C virus resistance to direct-acting antiviral agents
by: REN Shan, et al.
Published: (2015-11-01) -
Interferon Response in Hepatitis C Virus-Infected Hepatocytes: Issues to Consider in the Era of Direct-Acting Antivirals
by: Pil Soo Sung, et al.
Published: (2020-04-01) -
SASLT position statement on the direct-acting antiviral agents for the treatment of hepatitis C virus infection
by: Abdullah S Alghamdi, et al.
Published: (2015-01-01)